Deanne Marie Taylor, Ph.D.
Affiliations: | 2000-2001 | Bioinformatics Group | Pfizer Global R&D |
| 2001-2006 | Bioinformatics Group | Serono Laboratories | |
| 2003-2014 | Bioinformatics Graduate Program, Rabb Graduate School of Professional Studies | Brandeis University, Waltham, MA, United States | |
| 2006-2008 | Department of Biostatistics | Harvard School of Public Health, Boston, MA, United States | |
| 2008-2014 | Department of Obstetrics, Gynecology and Reproductive Science | Rutgers University and RMA of NJ | |
| 2014- | Department of Biomedical and Health Informatics | Children’s Hospital of Philadelphia, Philadelphia, PA, United States | |
| 2015- | Department of Pediatrics | University of Pennsylvania Perelman School of Medicine |
Area:
Bioinformatics, Computational Biology, Biophysics, Physical chemistryWebsite:
https://scholar.google.com/citations?user=42OPmz0AAAAJ&hl=enGoogle:
"Deanne Taylor CHOP UPenn"Bio:
Deanne is the Director of Bioinformatics at the Children's Hospital of Philadelphia, and a Research Assistant Professor of Pediatrics at the University of Pennsylvania. Her general areas of study are bioinformatics, biophysics, physical chemistry and computational biology. More specifically, she studies single-cell biology and biological energetics, in systems ranging from microorganisms to eukaryotic tissues including the human germ cell line.
Mean distance: (not calculated yet)
Cross-listing: Computational Biology Tree - Physics Tree
Parents
Sign in to add mentor| William Richard Dunham | grad student | 1995-2001 | University of Michigan | |
| ((Rotation mentor and collaborating graduate committee member.)) | ||||
| Ayyalusamy Ramamoorthy | grad student | 1996-2001 | University of Pennsylvania Medical School | |
| (Dissertation mentor. Nuclear Magnetic Resonance Coherence Transfer in a Homonuclear two spin-1/2 solid-state system) | ||||
| John Rogers | post-doc | 2000-2001 | Pfizer Global R&D | |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Winkelman JT, Pukhrambam C, Vvedenskaya IO, et al. (2020) XACT-Seq Comprehensively Defines the Promoter-Position and Promoter-Sequence Determinants for Initial-Transcription Pausing. Molecular Cell |
| Pastor S, Tran O, Jin A, et al. (2020) Optical mapping of the 22q11.2DS region reveals complex repeat structures and preferred locations for non-allelic homologous recombination (NAHR). Scientific Reports. 10: 12235 |
| Sewda A, Agopian AJ, Goldmuntz E, et al. (2020) Gene-based analyses of the maternal genome implicate maternal effect genes as risk factors for conotruncal heart defects. Plos One. 15: e0234357 |
| Zhang Y, Kim MS, Reichenberger ER, et al. (2020) Scedar: A scalable Python package for single-cell RNA-seq exploratory data analysis. Plos Computational Biology. 16: e1007794 |
| McDonald JT, Stainforth R, Miller J, et al. (2020) NASA GeneLab Platform Utilized for Biological Response to Space Radiation in Animal Models. Cancers. 12 |
| Beheshti A, Chakravarty K, Fogle H, et al. (2020) Author Correction: Multi-omics analysis of multiple missions to space reveal a theme of lipid dysregulation in mouse liver. Scientific Reports. 10: 1517 |
| Beheshti A, Chakravarty K, Fogle H, et al. (2019) Multi-omics analysis of multiple missions to space reveal a theme of lipid dysregulation in mouse liver. Scientific Reports. 9: 19195 |
| Mandl KD, Glauser T, Krantz ID, et al. (2019) Correction: The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system. Genetics in Medicine : Official Journal of the American College of Medical Genetics |
| Harrington CT, Sotillo E, Robert A, et al. (2019) Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma. Leukemia |
| Asnani M, Hayer KE, Naqvi AS, et al. (2019) Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19. Leukemia |